Generic placeholder image

Recent Patents on DNA & Gene Sequences

Editor-in-Chief

ISSN (Print): 1872-2156
ISSN (Online): 2212-3431

Recent Patents Related to Phosphorylation Signaling Pathway on Cancer

Author(s): Karina B. Acosta, Maria M. Tibolla, Maria M. Tiscornia, Maria A. Lorenzati and Pedro D. Zapata

Volume 5 , Issue 3 , 2011

Page: [175 - 184] Pages: 10

DOI: 10.2174/187221511797636257

Price: $65

Abstract

Phosphorylation and dephosphorylation play an important role in the regulation of growth factor and cytokine signal transduction to modulate cell proliferation, differentiation, survival, and apoptosis. In some cellular systems, the information suggests that EGFR, somatostatin receptors, SHP-1, Akt and PI3K can regulate carcinogenesis implied process through regulated the activity of NF-κB. Current patents related to signaling pathway that includes somatostatin receptors, phosphotyrosine phosphatases, tyrosine kinases, AKT/PKB and PI3K are focusing in diagnosis, prognosis and treatment. Many recent patented techniques include inhibition, antagonism or alternative therapeutic methods. Furthermore, it is necessary to deepen understanding of the molecular mechanisms involved in cancer to develop other alternative therapies focusing not only on new inhibitors.

Keywords: Phosphotyrosine kinases, phosphotyrosine phosphatases, signaling pathway, diagnosis, treatment, cancer, PDGF receptor, EGF receptor, VEGF receptor, mTorC1, DNA-PK, Akt, Duals PTP, Non Receptor Classic PTP, Receptor Classic PTP, SSTR2 / SHP-1, cleavable marker, retinal blindness


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy